Clinical Trials Browser

OTHER × BRCA1 Mutation × 90 days × Clear all

NCT06177171 2026-02-02

Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

Phase 1 Recruiting

BRCA1 Mutation